NLRP3 and cryopyrin-associated periodic syndrome: MCC950 is a small molecule inhibitor of NLRP3 that can alleviate a variety of inflammasome‐related diseases, including cryopyrin‐associated periodic syndrome (CAPS), experimental autoimmune encephalomyelitis (EAE), type 2 diabetes, and Alzheimer's disease (AD).191